SIGN IN
Email Address
Password

Neurogenic Overactive Bladder: Assessment and Management Strategies to Optimize Patient Outcomes



To start this activity, click "Begin" at the bottom of this page.

Neurogenic Overactive Bladder: Assessment and Management Strategies to Optimize Patient Outcomes

Release Date:

June 26, 2012

Expiration Date:

June 26, 2013

Topics:

Diabetes
Drug Information
Injury
Men's Health
Multiple Sclerosis
Musculoskeletal and Connective Tissue Disorders
Neurologic Disorders / Stroke
Women's Health

Specialty:

Men's Health
Neurology
Surgery-Other
Urology
Women's Health

Profession:

Nurse Practitioner
Physician
Physician Assistant

Format:

Webcast

Credits:

0.50 / AMA PRA Category 1 Credit(s)TM


Estimated Time to Complete:

45 minutes

Program Description:

Neurogenic overactive bladder (OAB) is a chronic and distressing medical condition that has profound physical, emotional, and financial ramifications for patients and is commonly seen in patients with neurologic conditions such as multiple sclerosis, spinal cord injury, cerebral vascular accident, Parkinson’s disease, and diabetes mellitus. This program educates physicians about up-to-date information with regard to assessing and optimally managing patients with neurogenic OAB to help improve physician knowledge and competence in the diagnosis and treatment of patients with this chronic and debilitating condition.

INTENDED AUDIENCE:

Urologists, urogynecologists, and other health care providers who treat patients with bladder dysfunction.

Activity Objectives:

After taking part in this educational activity, participants should be better able to:

  • Describe neurogenic overactive bladder (OAB) and its impact
  • Identify patients earlier for optimal individualized treatment, using diagnostic and assessment strategies
  • Select appropriate individualized therapy for neurogenic OAB, including evidence-based treatments and alternative therapeutic approaches
  • Identify strategies to assess patient satisfaction with treatment


Credits Type Accreditation Statement Designation Statement
0.50 AMA PRA Category 1 Credit(s)TM This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Boston University School of Medicine (BUSM) and Haymarket Medical Education. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. Boston University School of Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Faculty:

PROGRAM CHAIR
Michael B. Chancellor, MD

Professor, Oakland University
William Beaumont School of Medicine
Director, Neurourology Program
Department of Neurology
Beaumont Hospital, Royal Oak
Royal Oak, Michigan

PROGRAM FACULTY
Patrick J. Shenot, MD

Associate Professor of Urology
Residency Program Director
Vice Chairman, Academic Affairs
Department of Urology
Jefferson Medical College
Thomas Jefferson University
Philadelphia, Pennsylvania

CME COURSE ADVISOR
Linda Ng, MD

Assistant Professor of Urology
Boston University School of Medicine
Boston, Massachusetts

Click to Expand/Collapse Disclosures:

CONFLICT OF INTEREST DISCLOSURE STATEMENTS
Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve any apparent conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

FACULTY DISCLOSURES
Michael B. Chancellor, MD, receives grant/research support from, is a consultant for, and is on the speakers’ bureau for Allergan, Inc. Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Patrick J. Shenot, MD, receives grant/research support from Allergan, Inc. Dr. Shenot also receives grant/research support from Merck & Co., Inc. Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Linda Ng, MD, of Boston University School of Medicine, has no financial relationships to disclose.

Michael Burk, Program Manager of Boston University School of Medicine, has no financial relationships to disclose.

PUBLISHING STAFF DISCLOSURES
Mary Jo Krey, Eileen McCaffrey, MA, Debra A. Hughes, MS,
and Lori Marrese, of Haymarket Medical Education, have nothing to disclose with regard to commercial support.

DISCLOSURE OF OFF-LABEL USE
Unlabeled/investigational uses of commercial products are not discussed in this activity.

DISCLAIMER
THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR THE PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKE NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.

THIS ACTIVITY HAS BEEN PLANNED TO BE WELL BALANCED, OBJECTIVE, AND SCIENTIFICALLY RIGOROUS. INFORMATION AND OPINIONS OFFERED BY PRESENTERS REPRESENT THEIR VIEWPOINTS. CONCLUSIONS DRAWN BY THE AUDIENCE SHOULD BE DERIVED FROM CAREFUL CONSIDERATION OF ALL AVAILABLE SCIENTIFIC INFORMATION.

Accredited Provider:

This program is jointly sponsored by Boston University School of Medicine and Haymarket Medical Education.

                 


If you have any questions relating to the accreditation of this activity, please contact Boston University School of Medicine CME department at cme@bu.edu.

There is no commercial support for this enduring activity, however the content is based on a CME symposium presented in 2012 preceding the AUA Annual Meeting which was supported by an educational grant from .

PRIVACY POLICY
To view the Boston University School of Medicine privacy policy, please click here.

To view the myCME privacy policy, please click here.

Instructions:

To obtain credit, a score of 70% or better is required. This CE is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all post-test questions, completed the program evaluation, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.

Click to Expand/Collapse SYSTEM REQUIREMENTS:

WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.

MACINTOSH® SYSTEM REQUIREMENTS:
Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20 MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands of Colors”; Macromedia Flash Player 6 or higher.



Home | Browse By Disease | Browse By Specialty | Browse By Profession | About HME | Contact Us | Web Support

© 2013 Haymarket Media, Inc.

Your use of this website constitutes acceptance of Haymarket Medical Education's Privacy Policy and Terms & Conditions

Haymarket Medical Education